BioElectronics Expands to the Czech & Slovak Republic

FREDERICK, Md., Feb. 5, 2013 /PRNewswire/ — BioElectronics Corporation (BIEL: OTCPink), maker of consumer medical devices, announced today that easyMed s.r.o has begun sales and distribution of the ActiPatch® Musculoskeletal Pain Relief and RecoveryRx™ Postoperative and Wound Care Therapy brands in the Czech and Slovak Republic. easyMed s.r.o. employs 16 sales representatives that cover the entire … Continue Reading

BioElectronics Announces South Korean Patent Allowance for its Innovative OTC Pain Relief Medical Devices

FREDERICK, Md., Jan. 22, 2013 /PRNewswire/ — BioElectronics Corporation (OTCPK: BIEL), maker of consumer medical electronics, announced today that the Company has received patent allowance from the South Korean Intellectual Property office. While pulsed shortwave therapy is an established medical therapy, this South Korean patent and our 9 other approved and 8 pending are for a … Continue Reading

BioElectronics Expands Distribution to the Balkans

FREDERICK, Md., Oct. 4, 2012 /PRNewswire/ — BioElectronics Corporation (BIEL), maker of consumer medical electronics, announced today that it has agreed to distribution terms with ZEPHYRUS d.o.o. to distribute its ActiPatch® Musculoskeletal Pain Relief, Allay™ Menstrual Pain Relief and RecoveryRx™ Postoperative and Wound Care Therapy brands in the Balkan region. The countries involved include Albania, … Continue Reading

Chicago’s Stocks and Jocks Radio Show Features BioElectronics’ Consumer Medical Electronics Developments

FREDERICK, Md., Oct. 11, 2012 /PRNewswire/ — BioElectronics Corporation (BIEL: OTCPK), maker of consumer medical electronics products for pain management announced that Andrew J. Whelan, President, was featured on ‘The Stocks and Jocks Radio’ show to describe the Company’s rapid international expansion, its US FDA market clearance progress, recent published medical journal articles, new clinical studies, … Continue Reading

BioElectronics Files Form 15 With Securities and Exchange Commission

FREDERICK, MD–(Marketwire – Apr 19, 2011) – BioElectronics Corp. (PINKSHEETS: BIEL), the maker of disposable drug-free anti-inflammatory devices, today announced that it has filed a Form 15 with the SEC terminating the registration of the Company’s Common Stock under Section 12(g) of the Securities Exchange Act of 1934. As a result of this filing, the … Continue Reading